Related Experiment Video
Updated: May 31, 2026

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease
Srikanth Givvimani1, Natia Qipshidze, Neetu Tyagi
1Department of Physiology and Biophysics, University of Louisville School of Medicine Louisville, Kentucky.
Insights
High homocysteine (HHcy) levels cause heart failure by disrupting cell communication and function. Blocking NMDA-R1 receptors with MK-801 shows promise in mitigating these harmful effects and preventing sudden cardiac death.
Area of Science:
- Cardiovascular Research
- Molecular Cardiology
- Biochemistry
Background:
- Elevated homocysteine (HHcy) is linked to cardiac arrhythmia and sudden cardiac death (SCD).
- HHcy disrupts cardiac cell function by increasing iNOS, activating MMPs, degrading connexin-43, and altering collagen/elastin ratios.
- This leads to impaired cardiac conduction and endothelial-myocyte (E-M) uncoupling.
Purpose of the Study:
- To investigate the mechanisms by which HHcy induces cardiac failure, focusing on NMDA-R1 activation.
- To determine if blocking NMDA-R1 with dizocilpine (MK-801) can prevent or reverse HHcy-induced cardiac dysfunction.
- To elucidate the role of mitochondrial dysfunction and E-M uncoupling in HHcy-related heart disease.
Main Methods:
- Created chronic volume overload heart failure using aorta-venacava (AV) fistula in mice.
- Induced HHcy by administering homocysteine in drinking water.
- Administered MK-801 to block NMDA-R1, followed by EKG, echocardiography, and molecular analyses of cardiac tissue and endothelial cells.
Main Results:
- HHcy and AVF induced systolic and diastolic heart failure, characterized by increased MMP-9, collagen degradation, and decreased elastin.
- Mitochondrial dysfunction was evident with increased NOX4 and decreased peroxiredoxin.
- MK-801 treatment significantly mitigated cardiac contractile dysfunction, suggesting NMDA-R1's critical role.
Conclusions:
- HHcy exacerbates endothelial-myocyte uncoupling and cardiac failure, partly through NMDA-R1 activation.
- Mitochondrial dysfunction and altered extracellular matrix contribute to HHcy-induced heart disease.
- Targeting NMDA-R1 presents a potential therapeutic strategy for HHcy-related cardiac arrhythmias and sudden cardiac death.
Abstract:
Elevated levels of homocysteine (Hcy) known as hyperhomocysteinemia (HHcy) is associated with cardiac arrhythmia and sudden cardiac death (SCD). Hcy increases iNOS, activates matrix metalloproteinase (MMP), disrupts connexin-43 and increases collagen/elastin ratio. The disruption of connexin-43 and accumulation of collagen (fibrosis) interupt cardiac conduction and attenuate NO transport from endothelium to myocyte (E-M) causing E-M uncoupling. We hypothesize that Hcy increases mtNOS, metalloproteinase activity, disrupts connexin-43, exacerbates endothelial-myocyte uncoupling, and induces cardiac failure by activating NMDA-R1 in structural heart disease. Chronic volume overload heart failure was created by aorta-venacava (AV) fistula. HHcy was induced by adminstrering Hcy in drinking water. NMDA-R1 was blocked by dizocilpine (MK-801). EKG and M-mode Echocardiography was performed. The E-M coupling was determined in cardiac rings. LV mitochondria was isolated. Levels of NMDA-R1, peroxiredoxin, NOX4, and mtNOS were measured. The degradation of connexin-43, collagen and elastin was measured by Western blot analysis. Mouse cardiac endothelial cells were cultured with or without Hcy or MK-801. The results suggest systolic and diastolic heart failure in HHcy and AVF mice. The levels of connexin, collagen degradation and MMP-9 were increased. The elastin was decreased in HHcy and AVF hearts. The mitochondrial NOX4 increased and peroxiredoxin was decreased. The mtNOS activity was synergistically increased in HHcy, AVF and HHcy+AVF hearts. The cardiac contraction and endothelial dependent relaxation was attenutated in HHcy and AVF hearts. Interestingly, the treatment with MK-801 mitigated the contractile dysfunction. These studies delineated the mechanism of Hcy-dependent endothelial-myocyte uncoupling in cardiac arrhythmia and failure, and have therapeutic ramifications for sudden cardiac death.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Electrophysiology of Normal Cardiac Rhythm
Dysrhythmias I: Introduction
Dysrhythmias V: Evaluating Dysrhythmias
